ID: ALA2376170

Max Phase: Preclinical

Molecular Formula: C22H25N5OS2

Molecular Weight: 439.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CSc1ccc(Cc2sc(NC(C)=O)nc2CCc2ccc(NC(=N)N)cc2)cc1

Standard InChI:  InChI=1S/C22H25N5OS2/c1-14(28)25-22-27-19(12-7-15-3-8-17(9-4-15)26-21(23)24)20(30-22)13-16-5-10-18(29-2)11-6-16/h3-6,8-11H,7,12-13H2,1-2H3,(H4,23,24,26)(H,25,27,28)

Standard InChI Key:  QZWCQFQXWRKWTD-UHFFFAOYSA-N

Associated Targets(Human)

Amine oxidase, copper containing 450 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Amine oxidase, copper containing 122 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 439.61Molecular Weight (Monoisotopic): 439.1501AlogP: 4.50#Rotatable Bonds: 8
Polar Surface Area: 103.89Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.25CX Basic pKa: 7.59CX LogP: 4.40CX LogD: 4.25
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.23Np Likeness Score: -1.14

References

1. Inoue T, Morita M, Tojo T, Nagashima A, Moritomo A, Imai K, Miyake H..  (2013)  Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2.,  21  (9): [PMID:23540955] [10.1016/j.bmc.2013.02.048]

Source